Antonella Papa

13PUBLICATIONS
74CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 10, 2026
Genetic Ablation and Multi-Omics Profiling Reveal CEP55 as a Key Driver of Tumorigenesis in Diverse Cancer Models.

|Dec 17, 2025
Non-redundant roles of the phosphoinositide phosphatases PTEN and PIPP in PI3K/AKT signaling in breast cancer.

Lisa M Ooms, Daniel T Ferguson, Samuel J Rodgers

|May 24, 2024
Oncogenic Pathways and Targeted Therapies in Ovarian Cancer.

Carolina Lliberos, Gary Richardson, Antonella Papa

|Jan 25, 2024
Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer.

Hon Yan Kelvin Yip, Sung-Young Shin, Annabel Chee

|May 01, 2023
Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouse.

James R W Conway, Sean C Warren, Young-Kyung Lee

|May 06, 2022
Distinctive molecular features of regenerative stem cells in the damaged male germline.

Hue M La, Jinyue Liao, Julien M D Legrand

Pageof 3

Frequent Collaborators

3 joint publications

Catriona A McLean

3 joint publications

Lisa M Ooms

3 joint publications

Hon Yan Kelvin Yip

3 joint publications

John G Clohessy